Hyman Scott, MD

Title(s)Volunteer Assistant Clinical Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San FranciscoResidency 2009Internal Medicine
    Yale School of MedicineMedical School2006
    University of California, San FranciscoFellowship2014Infectious Diseases

    Collapse Overview 
    Collapse webpage

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial. Lancet HIV. 2025 Jun; 12(6):e405-e415. Seaton KE, Paez CA, Yu C, Karuna ST, Gamble T, Miner MD, Heptinstall J, Zhang L, Gao F, Yacovone M, Spiegel H, Dumond JB, Anderson M, Piwowar-Manning E, Dye B, Tindale I, Proulx-Burns L, Trahey M, Takuva S, Takalani A, Bailey VC, Kalams SA, Scott H, Mkhize NN, Weiner JA, Ackerman ME, McElrath MJ, Pensiero M, Barouch DH, Montefiori D, Tomaras GD, Corey L, Cohen MS, Huang Y, Mahomed S, Siegel M, Kelley CF, HVTN 140/HPTN 101 study team. PMID: 40441807.
      View in: PubMed   Mentions:
    2. Developing a Novel Mobile App to Support HIV Testing and Pre-Exposure Prophylaxis Uptake Among Men Who Have Sex With Men: Formative and Technical Pilot Study. JMIR Hum Factors. 2025 May 29; 12:e62830. Liu AY, Torres TS, Alleyne CD, Vinson J, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Muessig KE, Buchbinder SP, Sullivan P, Hightow-Weidman LB, Scott H. PMID: 40440084.
      View in: PubMed   Mentions:    Fields:    
    3. Sustained Effectiveness of Doxycycline Post-Exposure-Prophylaxis in a Large Sexual Health Clinic over 96 Weeks: An Interrupted Time Series Analysis. Clin Infect Dis. 2025 May 06. Spinelli MA, Heise MJ, Roman J, Bena J, Barry MP, Buchbinder SP, Scott HM. PMID: 40327542.
      View in: PubMed   Mentions:    Fields:    
    4. Innovation in Providing Equitable Pre-exposure Prophylaxis Services in the United States: Expanding Access in Nontraditional Settings. J Acquir Immune Defic Syndr. 2025 Apr 15; 98(5S):e156-e169. Mantell JE, Bauman LJ, Bonett S, Buchbinder S, Hoffman S, Storholm ED, McCoy K, Rael CT, Cowan E, Gonzalez-Argoti T, Safa H, Scott H, Murtaugh KL, Wilson NL, Liu A. PMID: 40163068.
      View in: PubMed   Mentions:    Fields:    
    5. Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension. Lancet Infect Dis. 2025 Mar 24. Luetkemeyer AF, Donnell D, Cohen SE, Dombrowski JC, Grabow C, Haser G, Brown C, Cannon C, Malinski C, Perkins R, Nasser M, Lopez C, Suchland RJ, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C. PMID: 40147465.
      View in: PubMed   Mentions:    Fields:    
    6. Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends. JAMA Intern Med. 2025 Mar 01; 185(3):266-272. Sankaran M, Glidden DV, Kohn RP, Nguyen TQ, Bacon O, Buchbinder SP, Gandhi M, Havlir DV, Liebi C, Luetkemeyer AF, Nguyen JQ, Roman J, Scott H, Torres TS, Cohen SE. PMID: 39761052; PMCID: PMC11877200.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial. JMIR Public Health Surveill. 2025 Feb 05; 11:e63428. Biello KB, Mayer KH, Scott H, Valente PK, Hill-Rorie J, Buchbinder S, Ackah-Toffey L, Sullivan PS, Hightow-Weidman L, Liu AY. PMID: 39908084; PMCID: PMC11840373.
      View in: PubMed   Mentions: Translation:HumansPHPublic Health
    8. Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration. AIDS Care. 2024 Nov; 36(11):1704-1718. Velloza J, Liu AY, Katz AWK, van der Straten A, Siegler AJ, Scott H, Wilde G, Lockard A, Christie RH, Buchbinder SP. PMID: 39222964; PMCID: PMC11511627.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120. J Infect Dis. 2024 Aug 16; 230(2):e405-e415. Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, Keefer M, Edupuganti S, Rodriguez B, Frank I, Scott H, Stranix-Chibanda L, Gurunathan S, Koutsoukos M, Van Der Meeren O, DiazGranados CA, Paez C, Andersen-Nissen E, Kublin J, Corey L, Ferrari G, Tomaras G, McElrath MJ. PMID: 37795976; PMCID: PMC11326849.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    10. Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119. JCI Insight. 2024 Aug 01; 9(18). Kalams SA, Felber BK, Mullins JI, Scott HM, Allen MA, De Rosa SC, Heptinstall J, Tomaras GD, Hu J, DeCamp AC, Rosati M, Bear J, Pensiero MN, Eldridge J, Egan MA, Hannaman D, McElrath MJ, Pavlakis GN, HIV Vaccine Trials Network 119(HVTN 119) Study Team. PMID: 39088271; PMCID: PMC11466283.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    11. Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users. AIDS. 2024 Sep 01; 38(11):1671-1676. Martinson T, Montoya R, Moreira C, Kuncze K, Sassaman K, Heise MJ, Glidden DV, Amico KR, Arnold EA, Buchbinder SP, Ewart LD, Carrico A, Wang G, Okochi H, Scott HM, Gandhi M, Spinelli MA. PMID: 38905507; PMCID: PMC11293961.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial. JMIR Form Res. 2024 Mar 27; 8:e54073. Liu AY, Alleyne CD, Doblecki-Lewis S, Koester KA, Gonzalez R, Vinson J, Scott H, Buchbinder S, Torres TS. PMID: 38536232; PMCID: PMC11007601.
      View in: PubMed   Mentions:
    13. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. EBioMedicine. 2024 Feb; 100:104987. Miner MD, deCamp A, Grunenberg N, De Rosa SC, Fiore-Gartland A, Bar K, Spearman P, Allen M, Yu PC, Manso B, Frahm N, Kalams S, Baden L, Keefer MC, Scott HM, Novak R, Van Tieu H, Tomaras GD, Kublin JG, McElrath MJ, Corey L, Frank I, HVTN 085 Study Team. PMID: 38306894; PMCID: PMC10847480.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    14. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023 12; 10(12):e767-e778. Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team. PMID: 37952550; PMCID: PMC11375758.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    15. Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June-September 2022. Emerg Infect Dis. 2023 11; 29(11):2307-2314. Minhaj FS, Singh V, Cohen SE, Townsend MB, Scott H, Szumowski J, Hare CB, Upadhyay P, Reddy J, Alexander B, Baird N, Navarra T, Priyamvada L, Wynn N, Carson WC, Odafe S, Guagliardo SAJ, Sims E, Rao AK, Satheshkumar PS, Weidle PJ, Hutson CL. PMID: 37832516; PMCID: PMC10617324.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    16. New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact? JAMA. 2023 08 22; 330(8):699-701. Liu AY, Scott HM, Buchbinder SP. PMID: 37606684; PMCID: PMC10586231.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    17. Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. Vaccine. 2023 07 25; 41(33):4899-4906. Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A, COVID-19 Prevention Network CoVPN. PMID: 37385888; PMCID: PMC10288314.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Prevention, treatment and cure of HIV infection. Nat Rev Microbiol. 2023 10; 21(10):657-670. Landovitz RJ, Scott H, Deeks SG. PMID: 37344551.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    19. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 04 06; 388(14):1296-1306. Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C, DoxyPEP Study Team. PMID: 37018493; PMCID: PMC10140182.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansPHPublic Health
    20. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. J Clin Invest. 2023 02 15; 133(4). Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, Frahm N, Elizaga ML, Maenza J, Scott H, Mayer KH, Goepfert PA, Edupuganti S, Pantaleo G, Hutter J, Morris DE, De Rosa SC, Geraghty DE, Robb ML, Michael NL, Fischer W, Giorgi EE, Malhi H, Pensiero MN, Ferrari G, Tomaras GD, Montefiori DC, Gilbert PB, McElrath MJ, Haynes BF, Korber BT, Baden LR, NIAID HVTN 106 Study Group. PMID: 36787249; PMCID: PMC9927951.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    21. Laboratory validation and clinical performance of a saliva-based test for monkeypox virus. J Med Virol. 2023 01; 95(1):e28191. Allan-Blitz LT, Carragher K, Sukhija-Cohen A, Ritchie P, Scott H, Li H, Klausner JD. PMID: 36183189; PMCID: PMC10091791.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    22. Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men. AIDS Behav. 2023 Feb; 27(2):719-732. Buchbinder SP, Siegler AJ, Coleman K, Vittinghoff E, Wilde G, Lockard A, Scott H, Anderson PL, Laborde N, van der Straten A, Christie RH, Marlborough M, Liu AY. PMID: 35984607; PMCID: PMC9908647.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    23. The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions. AIDS. 2022 11 01; 36(13):1783-1789. Saberi P, Stoner MCD, Ming K, Lisha NE, Hojilla JC, Scott HM, Liu AY, Steward WT, Johnson MO, Neilands TB. PMID: 35730363; PMCID: PMC9529898.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    24. Lessons Learned from an HIV Pre-Exposure Prophylaxis Coordination Program in San Francisco Primary Care Clinics. AIDS Res Hum Retroviruses. 2022 08; 38(8):611-614. Shrestha I, Ming K, Jimenez V, Wendelborn J, Vazquez A, Steward W, Scott H, Saberi P. PMID: 35592996; PMCID: PMC9419977.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    25. Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics. Open Forum Infect Dis. 2022 Feb; 9(2):ofab657. Saberi P, Ming K, Shrestha I, Scott H, Thorson B, Liu A. PMID: 35087913; PMCID: PMC8789566.
      View in: PubMed   Mentions: 5  
    26. Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):340-347. Le Guillou A, Buchbinder S, Scott H, Liu A, Havlir D, Scheer S, Jenness SM. PMID: 34354011; PMCID: PMC8556308.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    27. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 08 12; 385(7):595-608. Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team. PMID: 34379922; PMCID: PMC8448593.
      View in: PubMed   Mentions: 279     Fields:    Translation:HumansPHPublic Health
    28. Lessons From Mass-Testing for Coronavirus Disease 2019 in Long-Term Care Facilities for the Elderly in San Francisco. Clin Infect Dis. 2021 06 01; 72(11):2018-2020. Louie JK, Scott HM, DuBois A, Sturtz N, Lu W, Stoltey J, Masinde G, Cohen S, Sachdev D, Philip S, Bobba N, Aragon T, San Francisco Department of Public Health COVID-19 Skilled Nursing Facility Outbreak Response Team. PMID: 32687150; PMCID: PMC7454340.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsPHPublic Health
    29. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):e173-e176. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. PMID: 33534275; PMCID: PMC8026519.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    30. Engaging youth in mHealth: what works and how can we be sure? Mhealth. 2021; 7:23. Hightow-Weidman LB, Horvath KJ, Scott H, Hill-Rorie J, Bauermeister JA. PMID: 33898592; PMCID: PMC8063019.
      View in: PubMed   Mentions: 13  
    31. HIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with men. Mhealth. 2021; 7:26. Biello KB, Horvitz C, Mullin S, Mayer KH, Scott H, Coleman K, Dormitzer J, Norelli J, Hightow-Weidman L, Sullivan P, Mimiaga MJ, Buchbinder S, Bojan K, Futterman D, Emmanuel P, Liu A. PMID: 33898595; PMCID: PMC8063023.
      View in: PubMed   Mentions: 23  
    32. Mobile app development in health research: pitfalls and solutions. Mhealth. 2021; 7:32. Siegler AJ, Knox J, Bauermeister JA, Golinkoff J, Hightow-Weidman L, Scott H. PMID: 33898601; PMCID: PMC8063010.
      View in: PubMed   Mentions: 11  
    33. Comparison of symptomatic and asymptomatic infections due to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in San Francisco long-term care facilities. Infect Control Hosp Epidemiol. 2022 Jan; 43(1):123-124. Louie JK, Stoltey JE, Scott HM, Trammell S, Ememu E, Samuel MC, Aragon TJ, Masinde G. PMID: 33308337; PMCID: PMC7783077.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    34. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020; 15(10):e0240745. Saberi P, Ming K, Scott H, Liu A, Steward W. PMID: 33064763; PMCID: PMC7567425.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    35. COVID-19-Associated Deaths in San Francisco: the Important Role of Dementia and Atypical Presentations in Long-term Care Facilities. J Gen Intern Med. 2020 11; 35(11):3413-3415. Louie JK, Scott HM, Lu W, Chodos A, DuBois A, Sturtz N, Stoltey J. PMID: 32935309; PMCID: PMC7491360.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    36. Early COVID-19 Successes in Skilled Nursing Facilities in San Francisco. J Am Geriatr Soc. 2020 12; 68(12):2744-2745. Louie JK, Stoltey J, Scott HM, DuBois A, Golden L, Philip S, Aragón TJ. PMID: 33411328.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    37. Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS Behav. 2020 Sep; 24(9):2509-2519. Laborde ND, Kinley PM, Spinelli M, Vittinghoff E, Whitacre R, Scott HM, Buchbinder SP. PMID: 32048078; PMCID: PMC8054778.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    38. The importance of PrEP persistence in preventing HIV infections on PrEP. J Int AIDS Soc. 2020 08; 23(8):e25578. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. PMID: 32844591; PMCID: PMC7448189.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    39. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 07 14; 10(7):e040734. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. PMID: 32665393; PMCID: PMC7454188.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    40. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States. J Int AIDS Soc. 2020 04; 23(4):e25472. Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. PMID: 32294338; PMCID: PMC7159249.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    41. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. J Gen Intern Med. 2020 04; 35(4):1285-1288. Saberi P, Scott HM. PMID: 31965523; PMCID: PMC7174437.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    42. Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States. AIDS Behav. 2020 Jan; 24(1):274-283. Scott H, Vittinghoff E, Irvin R, Liu A, Nelson L, Del Rio C, Magnus M, Mannheimer S, Fields S, Van Tieu H, Kuo I, Shoptaw S, Grinsztejn B, Sanchez J, Wakefield S, Fuchs JD, Wheeler D, Mayer KH, Koblin BA, Buchbinder S. PMID: 31352633; PMCID: PMC6954959.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    43. Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics. AIDS. 2019 11 15; 33(14):2189-2195. Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S. PMID: 31436610; PMCID: PMC6832847.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    44. HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence. JAMA. 2019 06 11; 321(22):2172-2174. Scott H, Volberding PA. PMID: 31184721.
      View in: PubMed   Mentions: 4     Fields:    Translation:CellsPHPublic Health
    45. STIs: an unintended consequence of improved sexual health? Lancet HIV. 2019 07; 6(7):e415-e416. Scott HM, Buchbinder SP. PMID: 31178285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    46. A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru. Vaccine. 2019 06 27; 37(29):3911-3917. Andrasik M, Grove D, Broder G, Scott H, Allen M, Karuna S. PMID: 31176538; PMCID: PMC6699617.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    47. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. J Acquir Immune Defic Syndr. 2019 06 01; 81(2):158-162. Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY. PMID: 31095005; PMCID: PMC6530484.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    48. High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application. Sex Transm Dis. 2019 04; 46(4):e32-e34. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Coleman K, Buchbinder SP. PMID: 30870327; PMCID: PMC6425754.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    49. Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network. Open Forum Infect Dis. 2019 Apr; 6(4):ofz101. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP. PMID: 30949540; PMCID: PMC6441570.
      View in: PubMed   Mentions: 39  
    50. Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 25; 8(1):e10659. Liu A, Coleman K, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Sullivan P, Hightow-Weidman L, Buchbinder S, Scott H. PMID: 30681964; PMCID: PMC6367663.
      View in: PubMed   Mentions: 33  
    51. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. PMID: 30503324; PMCID: PMC6541554.
      View in: PubMed   Mentions: 31     Fields:    
    52. 2272. High Interest in Doxycycline for Sexually Transmitted Infection Post-Exposure Prophylaxis (Doxy-PEP) in a Multi-city Survey of Men Having Sex With Men (MSM) Using a Social-Networking App. Open Forum Infectious Diseases. 2018 Nov 26; 5(suppl_1):s672-s673. Spinelli SM, Scott SH, Vittinghoff VE, Liu LA, Coleman CK, Gandhi GM, Buchbinder BS. .
      View in: Publisher Site   Mentions:
    53. 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report. Open Forum Infectious Diseases. 2018 Nov 26; 5(suppl_1):s396-s397. Cohen CS, Sachdev SD, Lee LS, Scheer SS, Bacon BO, Chen CM, Norvell NC, Okochi OH, Anderson AP, Coffey CS, Scott SH, Havlir HD, Gandhi GM. .
      View in: Publisher Site   Mentions:
    54. Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):347-351. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Gandhi M, Buchbinder SP. PMID: 30085955; PMCID: PMC6185763.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    55. Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):38-45. Lightfoot MA, Campbell CK, Moss N, Treves-Kagan S, Agnew E, Kang Dufour MS, Scott H, Sa'id AM, Lippman SA. PMID: 29771792.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    56. Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States. J Adolesc Health. 2018 08; 63(2):242-244. Hart-Cooper GD, Allen I, Irwin CE, Scott H. PMID: 29843969.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    57. Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network. Open Forum Infect Dis. 2018 Jun; 5(6):ofy099. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Buchbinder SP. PMID: 29977959; PMCID: PMC6016415.
      View in: PubMed   Mentions: 14  
    58. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1). Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. PMID: 30637375; PMCID: PMC6325636.
      View in: PubMed   Mentions: 16  
    59. A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav. 2017 Oct; 21(10):2958-2972. Levy ME, Phillips G, Magnus M, Kuo I, Beauchamp G, Emel L, Hucks-Ortiz C, Hamilton EL, Wilton L, Chen I, Mannheimer S, Tieu HV, Scott H, Fields SD, Del Rio C, Shoptaw S, Mayer K. PMID: 28352984; PMCID: PMC5623129.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    60. Distribution of Behavioral Patterns Before Infection Among San Francisco Men Who Have Sex With Men Newly Infected With HIV in 2014. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):528-534. Chen YH, McFarland W, Raymond HF, Scott HM, Vittinghoff E, Porco TC. PMID: 28481784; PMCID: PMC5649625.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    61. Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States. AIDS Res Hum Retroviruses. 2017 07; 33(7):745-748. Chen I, Zhang Y, Cummings V, Cloherty GA, Connor M, Beauchamp G, Griffith S, Rose S, Gallant J, Scott HM, Shoptaw S, Del Rio C, Kuo I, Mannheimer S, Tieu HV, Hurt CB, Fields SD, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. PMID: 28384058; PMCID: PMC5512295.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    62. Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav. 2017 Apr; 21(4):1163-1170. Latkin CA, Van Tieu H, Fields S, Hanscom BS, Connor M, Hanscom B, Hussen SA, Scott HM, Mimiaga MJ, Wilton L, Magnus M, Chen I, Koblin BA. PMID: 27480454; PMCID: PMC5288401.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    63. Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061). PLoS One. 2016; 11(12):e0167629. Chen I, Chau G, Wang J, Clarke W, Marzinke MA, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. PMID: 27936098; PMCID: PMC5147928.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    64. Navigating Opportunities, Learning and Potential Threats: Mentee Perspectives on Mentoring in HIV Research. AIDS Behav. 2016 09; 20 Suppl 2:258-64. Brewer RA, Dyer T, Watson CC, Scott H. PMID: 27424003; PMCID: PMC10938162.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    65. CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. HIV Clin Trials. 2016 07; 17(4):158-64. Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. PMID: 27300696; PMCID: PMC5003405.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    66. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther. 2016; 13:5. Scott HM, Klausner JD. PMID: 26793265; PMCID: PMC4719214.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansPHPublic Health
    67. Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United States. PLoS One. 2015; 10(12):e0146025. Scott HM, Irvin R, Wilton L, Van Tieu H, Watson C, Magnus M, Chen I, Gaydos C, Hussen SA, Mannheimer S, Mayer K, Hessol NA, Buchbinder S. PMID: 26720332; PMCID: PMC4697821.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    68. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr. 2015 Aug 01; 69(4):446-52. Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. PMID: 25861015; PMCID: PMC4482803.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    69. Examining levels of risk behaviors among black men who have sex with Men (MSM) and the association with HIV acquisition. PLoS One. 2015; 10(2):e0118281. Irvin R, Vallabhaneni S, Scott H, Williams JK, Wilton L, Li X, Buchbinder S, HPTN 061. PMID: 25688980; PMCID: PMC4331540.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    70. Peer social support is associated with recent HIV testing among young black men who have sex with men. AIDS Behav. 2014 May; 18(5):913-20. Scott HM, Pollack L, Rebchook GM, Huebner DM, Peterson J, Kegeles SM. PMID: 24065436; PMCID: PMC3965658.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansPHPublic Health
    71. Utilization of HIV prevention services across racial/ethnic groups among men who have sex with men in San Francisco, California, 2008. AIDS Behav. 2014 Apr; 18 Suppl 3:316-23. Scott HM, Fuqua V, Raymond HF. PMID: 23712733.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2014 Jan 01; 65(1):115-21. Scott HM, Vittinghoff E, Irvin R, Sachdev D, Liu A, Gurwith M, Buchbinder SP. PMID: 24419067; PMCID: PMC3894586.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    73. Atraumatic splenic rupture: an unusual manifestation of acute HIV infection. AIDS Patient Care STDS. 2011 Aug; 25(8):461-4. Vallabhaneni S, Scott H, Carter J, Treseler P, Machtinger EL. PMID: 21711142.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    74. Racial/ethnic and sexual behavior disparities in rates of sexually transmitted infections, San Francisco, 1999-2008. BMC Public Health. 2010 Jun 06; 10:315. Scott HM, Bernstein KT, Raymond HF, Kohn R, Klausner JD. PMID: 20525397; PMCID: PMC2903517.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis. 2008 Feb; 35(2):197-202. Scott H, Khoury J, Moore BA, Weissman S. PMID: 18216727.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    Hyman's Networks
    Concepts (209)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (50)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.